TI
CNTA

Trexquant Investment’s Centessa Pharmaceuticals CNTA Stock Holding History

Trexquant Investment’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.5M Buy
390,951
+244,428
+167% +$6.25M 0.11% 223
2025
Q4 		$3.66M Buy
146,523
+84,213
+135% +$2.13M 0.03% 743
2025
Q3 		$1.51M Sell
62,310
-89,042
-59% -$1.58M 0.02% 1015
2025
Q2 		$1.99M Sell
151,352
-112,642
-43% -$1.43M 0.02% 886
2025
Q1 		$3.8M Buy
263,994
+2,810
+1% +$46K 0.04% 611
2024
Q4 		$4.37M Buy
261,184
+90,233
+53% +$1.49M 0.05% 573
2024
Q3 		$2.73M Buy
170,951
+127,203
+291% +$1.56M 0.03% 690
2024
Q2 		$395K Sell
43,748
-52,783
-55% -$501K 0.01% 1308
2024
Q1 		$1.09M Buy
96,531
+82,177
+573% +$778K 0.02% 888
2023
Q4 		$114K Buy
+14,354
New +$96.2K ﹤0.01% 1363

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Trexquant Investment's CNTA Position: Q1 2026 in Review

Trexquant Investment increased its Centessa Pharmaceuticals (CNTA) stake by 167% in Q1 2026, buying an estimated $6.25M and bringing the position to 390,951 shares worth $15.5M. The position accounts for 0.11% of the portfolio, ranked #223.

Trexquant Investment first reported a position in CNTA in Q4 2023 and has held it in 10 quarters since. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Trexquant Investment held 390,951 shares of Centessa Pharmaceuticals worth $15.5M as of Q1 2026.
  • Trexquant Investment bought 244,428 Centessa Pharmaceuticals shares in Q1 2026, an estimated $6.25M.
  • Centessa Pharmaceuticals made up 0.11% of Trexquant Investment's portfolio in Q1 2026, its #223 holding.
  • Trexquant Investment first reported a position in Centessa Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.